Диссертация (1140527), страница 13
Текст из файла (страница 13)
No 1. - P. 247-254.10162.Capretti, A. [Changes in blood potassium induced by the abuse of3 beta 2-agonist drugs]. / A.Capretti, M.Dantes, R.De Gasperi // ClinTer. – 1987. – Vol.121, No 1. – P.41-4.63.Cates, C.J. Regular treatment with formoterol versus regulartreatment with salmeterol for chronic asthma: serious adverse events /C.J.Cates, T.J.Lasserson // Cochrane Database Syst Rev. – 2012. – No3. – P.CD00769564.Cazzola, M. Inhaled beta2-adrenoceptor agonists: cardiovascularsafety in patients with obstructive lung disease/ M.Cazzola,M.G.Matera, C.F.Donner // Drugs.
– 2005. – Vol.65, No 12. – P.1595–61065.Charlier, P. Asthma-related sudden death: Clinicopathologicalfeatures in 14 cases / P.Charlier, A.L.Naneix, L.Brun, et al. // La Revuede Médecine Légale. – 2012. – Vol.3, No 3. – P.115-119.66.Chowdhury, B.A. The FDA and safe use of long-acting beta-agonists in the treatment of asthma / B.A.Choudhury, G.Dal Pan // NEngl J Med. – 2010.
– Vol.362. – P.1169–117167.Chowdhury, B.A. Assessing the safety of adding LABAs toinhaled corticosteroids for treating asthma // B.A.Choudhury,S.M.Seymour, M.S.Levenson // N Engl J Med. – 2011. – Vol.364. –P.2473–247568.Cockcroft, D.W. Pharmacologic Therapy for Asthma: Overviewand Historical Perspective / D.W.Cockroft // Journal of ClinicalPharmacology. – 1999. – Vol.39. – P.216–22269.Conte, G. Evaluation of hyperkinetic cardiac arrhythmia inchronicobstructivebronchopneumopathy/G.Conte,S.Lauro,102M.Lazzarin, et al. // Minerva Cardio-angiol - 1997.
- Vol 45, No 9. - P.429-433.70.Crane, J. Cardiovascular and hypokalemic effects of inhaledsalbutamol, fenoterol and isoprenaline / J.Crane, C.Burgess, R.Beaslly,et al. // Thorax. -1989. - Vol 44, No 2. - P. 136-140.71.Du, J. A study of heart rate variability in asthma / J.Du, J.He,Y.Wang // Zhonghua Jie He He Hu Xi Za Zhi. - 2001. - Vol. 24, No 12.- P. 744-745.72.Eckberg, D.L. Physiological basis for human autonomic rhythms /D.L.Eckberg // Ann. Med. - 2000. - Vol.
32, No24. - P. 341-349.73.Eliasson, O. Recurrent respiratory failure in premenstrual asthma/ O.Eliasson, H.H.Scherzer // Conn Med. – 1984. – Vol.48. – P.777–778.74.Elming, H. QTc interval in the assessment of cardiac risk /H.Elming, B.Brendorp, L.Køber, et al. // Cardiac electrophysiologyreview.
- 2002. – Vol.6, No 3. – P.289-29475.Engström, G. Occurrence and prognostic significance ofventricular arrhythmia is related to pulmonary function: a study from"men born in 1914," Malmö, Sweden / G.Engström, P.Wollmer,B.Hedblad // Circulation. – 2001. – Vol.103, No 25. – P.3086-91.76.Emerman, С. Risk of toxicity in patients with elevatedtheophylline levels / С.Emerman, C.Devlin, A.Connors // Ann. Emerg.Med. - 1990. - Vol. 19, №6. - P. 643-648.77.Eryonucu, B.
K. N. M. Comparison of the acute effects ofsalbutamol and terbutaline on heart rate variability in adult asthmatic103patients / B.K.N.M.Eryonucu, K.Uzun, N.Güler, et al. // EuropeanRespiratory Journal. - 2001. - Vol.17, No 5. – P.863-867.78.Evans, R. Recent observations reflecting increases in mortalityfrom asthma / R.Evans // J. Allergy. Clin. Immunol - 1987. - Vol 80, No3. - P. 377-379.79.Fraser, P.M. The circumstances preceding death from asthma inyoung people in 1968 to 1969 / P.M.Fraser, F.E.Speizer, S.D.Waters, etal // Br J Dis Chest. - 1971.
– Vol. 65. - P.71–8480.Garcia-araújo, A.S. Increased sympathetic modulation anddecreased response of the heart rate variability in controlled asthma /A.S.Garcia-araújo, V.A.Pires di lorenzo, I.G.Labadessa, et al // JAsthma. – 2014. – No 1. – P.1-8.81.Garrard, C.S. Spectral analysis of heart rate variability inbronchial asthma / C.S.Garrard, A.Seidler, A.McKibben, et al. //Clinical Autonomic Research – 1992. - Vol.2, No 2. – P.105-11182.Getahun, D. Recent trends in asthma hospitalization and mortalityin the United States / D.Getahun, K.Demissie, G.G.Rhoads // J Asthma.– 2005.
- Vol.42. – P.373–37883.Global Initiative for Asthma. Global Strategy for AsthmaManagementandPrevention2014.Режимдоступа:http://www.ginasthma.org84.Gross, N.J. Effects of an anticholinergic bronchodilator on arterialblood gases of hypoxemic patients with chronic obstructive pulmonarydisease: comparison with a beta-adrenergic agent / N.J.Gross,Z.Bankwala // Am Rev Respir Dis.
– 1987. – Vol.136. – P.1091–109410485.Hanratty, C.G. Evaluation of the effect on heart rate variability of abeta2-adrenoceptor agonist and antagonist using non-linear scatterplotand sequence methods / C.G.Hanratty, B.Silke, J.G. Riddell // Br J ClinPharmacol. – 1999. – Vol.47. – P.157–16686.Heart Rate Variability. Standards of Measurement, PhysiologicalInterpretation, and Clinical Use. Task Force of the European Society ofCardiology the North American Society of Pacing Electrophysiology //Circulation. – 1996. – Vol.93. – P.1043-1065.87.Helfant, R.H.
Hypokalemia and arrhythmias / R.H.Helfant // TheAmerican journal of medicine – 1986. - Vol.80, No 4 - P.13-22.88.Jartti, T. Altered cardiovascular autonomic regulation aftersalbutamol treatment in astmatic children / T.Jartti, T.J.Kaila,K.U.Tahvanainen, et al. // Clin Physiol. – 1998. – Vol.18. – P.345-5389.Jartti, T. The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectralanalysis / T.Jartti, K.Tahvanainen, T.Vanto // Br J Clin Pharmacol. –1997. – Vol.43. – P.421-890.John, R.M.
Ventricular arrhythmias and sudden cardiac death /R.M.John, U.B.Tedrow, B.A.Koplan, et al // Lancet – 2012. – Vol.380,No 9852. – P.1520-991.Kannel, W.B. Heart rate and cardiovascular mortality: theFramingham Study / W.B.Kannel, C.Kannel, R.S.Paffenbarger, et al. //Am Heart J. – 1987. – Vol.113, No 6. – P.1489-9492.Kiely, D.G.
Abnormal myocardial repolarisation in response tohypoxaemia and fenoterol / D.G.Kiely, R.I.Cargill, A.Grove / Thorax –1995. – Vol.50.- P.1062–610593.Kjeldsen, K. Hypokalemia and sudden cardiac death / K.Kjeldsen// Exp Clin Cardiol. – 2010. – Vol.15, No 4. – P.e96-994.Klitzke, A. Cardiac arrhythmia in patients with chronicobstructive lung disease and therapy / A.Klitzke, C.Criee, K.Bethge, etal. // Pneumologie. - 1990. - Vol. 44. - Suppl 1 - P. 536-537.95.Kuo, T. Effect of aging on gender differences in neural control ofheart rate / T.Kuo, T.Lin, C.Yang et al // Am J Physiol Heart CircPhysiol.
– 1999. – Vol.277.- P. H2233-H223996.Lemaitre, M. Inhaled beta2adrenergic receptor agonists andprimary cardiac arrest / M.Lemaitre et al. // Am J Med. – 2002. –Vol.113. – P.711-71697.Lewis, M.J. Autonomic nervous system control of thecardiovascular and respiratory systems in asthma / M.J.Lewis,A.L.Short, K.E.Lewis // Respir Med. – 2006. – Vol.100, No 10.
–P.1688-70598.Lutfi, M.F. Autonomic modulations in patients with bronchialasthma based on short-term heart rate variability / M.F.Lutfi // LungIndia. – 2012. – Vol.29, No 3. – P.254-899.Malliani, A. Power spectral analysis of heart rate variability: atool to explore neural regulatory mechanisms / A.Malliani, F.Lombardi, M.Pagani // Br Heart J. - 1994. - Vol.71. – P.1-2.100.Malliani, A. Individual recognition by heart rate variability of twodifferent autonomic profiles related to posture / A.Malliani, M.Pagani,R.Furlan, et al. - Circulation.
– 1997. – Vol.96, No 12. – P.4143-5.106101.Masoli, M. The global burden of asthma: Executive summary ofthe GINA Dissemination Committee report / M.Masoli, D.Fabian,S.Holt, et al. // Allergy. – 2004. – Vol.59, No 5. – P.469–78.102.Mirdal, G.M. Asthma and menstruation: the relationship betweenpsychological and bronchial hyperreactivity / G.M.Mirdal, B.Petersson,B.Weeke // BMJ Psychol. – 1998. – Vol.71. – P.47–55.103.Molfino, N.A. Respiratory arrest in near-fatal asthma. /N.A.Molfino, L.J.Nannini, A.N.Martelli // New England Journal ofMedicine.
– 1991. – Vol.324, No 5. – P.285-288.104.Moorman, J.E. National surveillance for asthma: United States,1980–2004 / J.E.Moorman, R.A.Rudd, C.A.Johnson, et al. // MMWRSurveill Summ. - 2007. – Vol.56. – P.1–54.105.M orillo, С. Effects of autonomy manipulation on ventricularfibrillation and intemal cardiac defibrillation thresholds in pigs /C.Morillo, D.Jones, G.Klein // Pacing Clin. Electrophysiol. - 1996. Vol. 19 - P.1355-1362106.Morjaria, J.B.
Autonomic dysregulation: a mechanism of asthmadeath / J.B.Morjaria, T.Rowland, P.Tailor, et al. // Eur Respir J. – 2014.- Vol.44, No 5. – P.1357-60.107.Nadel, J.A. Autonomic control of airway smooth muscle andairway secretions / J.A.Nadel // Am Rev Respir Dis. – 1977. – Vol.115.– P.117–126108.Nelson, H.S. The Salmeterol Multicenter Asthma Research Trial.A comparison of usual pharmacotherapy for asthma or usualpharmacotherapyplussalmeterol/H.S.Nelson,S.T.Weiss,E.R.Bleecker, et al. // Chest. – 2006. – Vol.129.- P.15–26107109.O'Donnell, T.V.
Fenoterol and fatal asthma / T.V.O'Donnell,M.R.Sears, H.H.Rea // Lancet. – 1989. – No.2. – P. 45110.Oguzulgen, I.K. Airway inflammation in premenstrual asthma /I.K.Oguzulgen, H.Turktas, D.Erbas // J Asthma. – 2002. – Vol.39. –P.517–522111.Okin, P.M. Assessment of QT interval and QT dispersion forprediction of all-cause and cardiovascular mortality in AmericanIndianstheStrongHeartStudy/P.M.Okin,R.B.Devereux,B.V.Howard, et al. // Circulation.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
